Jan 05,2023

Mental Health App Woebot Passes ORCHA’s Rigorous New Digital Health Assessment Framework

Woebot, a mental health app from Woebot Health, has passed the rigorous new Digital Health Assessment Framework (DHAF) that aims to enhance health application standards in the United States. The open framework includes components to assess privacy and security, clinical assurance and safety, and usability, and was crafted to support U.S.-specific guidelines, regulations and best practices for digital health technologies.

PRODUCT

#cbt

#software

#chatbot

View Analyst & Ambassador Comments
Go to original news
Jan 11,2023

Woebot Health Names Trina Histon Vice President of Clinical Product Strategy

Woebot Health today announced that it has appointed Trina Histon, PhD, as its Vice President of Clinical Product Strategy. In the newly-created position, Histon will accelerate Woebot’s capabilities to integrate into care pathways and advance the software transformation of psychiatry, behavioral health and primary care. Histon’s expertise in embedding and deploying digital health solutions in care delivery spans more than two decades. Before joining Woebot Health, Histon was a Senior Principal Consultant in Kaiser Permanente’s Care Management Institute (CMI).

View Analyst & Ambassador Comments
Go to original news
Jan 23,2023

CSIT Awards $1.275 Million to 17 New Jersey Startups Focused on Supporting Maternal & Infant Health

The Commission on Science, Innovation and Technology (CSIT) Board yesterday awarded a combined $1.275 million in grants to 17 startups to accelerate the development of technologies, products, and services that support maternal and child wellbeing. The grants were awarded through CSIT’s Maternal and Infant Health Research & Development (R&D) Grant Program, which launched last June.

View Analyst & Ambassador Comments
Go to original news
Jan 23,2023

Woebot Health Enrolls First Patient in Pivotal Clinical Trial of WB001 for Postpartum Depression

Woebot Health today announced the enrollment of the first patient in a pivotal clinical trial to evaluate the safety and efficacy of WB001, an investigational digital therapeutic for postpartum depression (PPD) that was granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) in 2021. The multi-center, double-blind, randomized controlled study is actively recruiting women ages 22 to 45 who have given birth in the last three months and are experiencing mild to moderate PPD.

PRODUCT

#cbt

#software

#chatbot

View Analyst & Ambassador Comments
Go to original news
Jan 24,2023

Curebase Launches All-in-One Software and Trial Execution Package to Help Digital Therapeutics Companies Accelerate Clinical Trials

Curebase, a company committed to democratizing access to clinical trials, announced the release of its integrated software and services package for digital therapeutics (DTx) trials that accelerates enrollment and allows sponsors to launch their studies faster. The new Curebase digital therapeutics offering includes features, workflows, and tools built into the company's eClinical platform specifically made for and used in DTx studies. This also includes virtual site models, CRO services, and recruitment tactics tried and tested in digital therapeutic studies, allowing DTx sponsors to quickly launch a study with the confidence of proven execution.

PRODUCT

#software

View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

Wellbeing Digital to Participate in the Psychedelic Medicine Association Webinar

Wellbeing Digital Sciences Inc., an evidence-based mental healthcare company focused on the development and implementation of innovative clinical solutions, including psychedelic medicine and digital therapeutics as supported by clinical research, announces that Najla Guthrie, CEO of Wellbeing, will participate at the upcoming Psychedelic Medicine Association (PMA) Webinar on Thursday, January 26th at 5 pm Pacific, 8 pm Eastern.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Jan 25,2023

Study: New VR sensory room reduces anxiety in people with intellectual disability

A new VR programme with interactive sight, sound, and touch experiences has helped improve outcomes for adults with neurodevelopmental disabilities, including autism and intellectual disability. The five-month preliminary study evaluated the viability and benefits of using Devika's Evenness VR Sensory Space technology as an intervention tool among 31 adults with different neurodevelopmental disabilities and their carers. Based on pre and post-scores of the users, the technology helped reduce their anxiety, and in particular, lowered depressive symptoms among participants with depression.

CLINICAL STUDY

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Jan 26,2023

For many with mental health conditions, medication is the only option. That has to change.

Digital therapeutics is gaining traction as a major application in the field of mental health for several reasons. Firstly, mental health encompasses a variety of highly prevalent conditions like anxiety, depression, chronic pain, insomnia, and PTSD that affect around one in three individuals. Secondly, the existing treatments for these conditions, such as commonly prescribed medications, have inadequate efficacy and may result in significant side effects. Thirdly, during the pandemic, mental health has become a top three priority for governments, health systems, and employers to address more effectively. Additionally, patient preferences are also contributing to this trend, with 75% of individuals expressing a preference for non-pharmaceutical treatments.

View Analyst & Ambassador Comments
Go to original news
Jan 26,2023

State-by-state licensure is anachronistic in the age of teletherapy, providers say

The survey of 200 therapists performed by Alma found that 70% of therapists have stopped treating a patient because they left the state. Providers in the U.S. benefited from generous licensure policies during the COVID-19 pandemic that enabled cross-state care but many states are now beginning to roll those policies back.

#telehealth

#virtual care

View Analyst & Ambassador Comments
Go to original news
Jan 26,2023

Sharecare launches VR program to improve well-being of American workforce and bring innovation to exercise

Sharecare, the digital health company that helps people manage all their health in one place, today announced the launch of Get Active, a new program to help employers encourage exercise among their workforces in a fun, approachable, and accessible way, using the immersive power of virtual reality (VR). In a pilot conducted in late 2022 with Lennar Corporation, Sharecare's Get Active program generated promising results with an engagement rate of 82% and a 280% increase in average weekly exercise minutes per person compared to pre-program.

PRODUCT

#coaching

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Subscribe to MENTAL HEALTH